News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Active Biotech AB (BTPC) Release: Laquinimod Highlights From Teva Pharmaceutical Industries Limited (TEVA) Investor Day December 11



12/12/2012 9:15:24 AM

Lund, Sweden, December 12, 2012 - Active Biotech's (NASDAQ OMX NORDIC: ACTI) partner Teva Pharmaceutical Industries Ltd. hosted yesterday, December 11, 2012, an investor meeting. Teva has a license to develop and commercialize Active Biotech's molecule laquinimod.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES